Medical oncology for companion animals, canine lymphoma, canine hemangiosarcoma, chemotherapy
Clinical characterization of canine lymphoma and chemotherapy resistance mechanisms; prevention of chemotherapy side effects; applications for treatment with oral low-dose metronomic chemotherapy and methods to assess clinical response; novel therapies for canine lymphoma and hemangiosarcoma.
Crouse, Z., Phillips, B., Flory, A., Mahoney, J., Richter, K., Kidd, L. Post-chemotherapy perforation in cats with discrete intermediate- or large-cell gastrointestinal lymphoma J Feline Med Surg 20: 696-703, 2018.Mahoney, J. A., Fisher, J. C., Snyder, S. A., Hauck, M. L. Feasibility of using gene expression analysis to study canine soft tissue sarcomas Mamm Genome 21: 577-82, 2010.Mahoney, J. A., Bergman, P. J., Camps-Palau, M. A., Hull, T. L. Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat J Vet Intern Med 21: 872-3, 2007.
BA (Biological Sciences) Wellesley College, 2002DVM (Veterinary Medicine) North Carolina State University College of Veterinary Medicine, 2006